代表性成果
论文 (#表示通讯作者;*共享第一作者)
1. Bai F, Liu S, Liu1 X, Hollern DP, Scott A, Wang C, Zhang LH, Fan C, Fu L, Perou CM, Zhu WG and Pei XH(2021) PDGFRβis an essential therapeutic target3for BRCA1-deficient mammary tumors。Breast Cancer Research (2021)23:10
2. Wang C, Bai F#, Zhang LH, Scott A, Li E, Pei XH. (2018) Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression. Breast Cancer Research. 20(1);74:1-17.
3. Benitez A, Liu W, Palovcak A, Wang G, Moon J, An K, Kim A, Zheng K, Zhang Y, Bai F, Mazin AV, Pei XH, Yuan F, Zhang Y. (2018) FANCA promotes DNA double strand break repair by catalyzing single-strand annealing and strand exchange. Molecular Cell. 16;71(4):621-628.
4. Scott A, Bai F#, Chan HL, Liu S, Slingerland JM, Robbins DJ, Capobianco AJ, Pei XH. (2017) p16 loss rescues functional decline of Brcac1-deficient mammary stem cells. Cell Cycle. 6(8):759-764.
5. Ma Q*, Grati M*, Bai F*, Pei J, Pei XH, Liu X. (2016) Rescue from early onset hearing loss in a mouse model lacking the cyclin-dependent kinase inhibitor p19Ink4d. Cell Death and Disease. 10;7:e2131. *equal contribution.
6. Bai F, Chan HL, Scott A, Smith MD, Fan C, Herschkowitz JI, Perou, CM, Livingstone AS, Robbins DJ, Capobianco AJ, Pei XH. (2014) BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. Cancer Research. 74(21):6161-6172.
6. Bai F, Chan HL, Smith MD, Kiyokawa H, Pei XH. (2014) p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation. Molecular and Cellular Biology. 34(12): 2121-2134. (Cover article).
7. Bai F, Smith MD, Chan HL, Pei XH. (2013) Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation. Oncogene. 30;32(22): 2715-2725. Featured Article.Commentary in Oncogene: BRCA1 mutations and luminal-basal transformation. Ng T, Irshad S, Stebbing J. 2013 May 30;32(22):2712-2714.
8. Pei XH, Bai F, Li Z, Smith MD, Whitewolf G, Jin R, and Xiong Y. (2011) Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis. Cancer Research. 71, 2969-2977.
9. Pei XH*, Bai F*, Smith MD, Usary J, Fan C, Pai SY, Ho IC, Perou CM, Xiong Y. (2009) CDK inhibitor p18INK4c is a downstream target of GATA3 and controls mammary luminal progenitor cell proliferation and tumorigenesis. Cancer Cell, 15, 389-401. *equal contribution.
10. Pei XH*, Bai F*, Smith MD, Xiong Y. (2007) p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers. Cancer Research. 67, 3162-3170. *equal contribution.
11. Bai F*, Pei XH*, Nishikawa T, Smith MD, Xiong Y. p18Ink4c, but not p27Kip1, Collaborates with Men1 to Suppress Neuroendocrine Organ Tumors. Molecular and Cellular Biology, 27, 1495-1504: 2007 *equal contribution.
12. Bai F*, Pei XH*, Pandolfi PP, Xiong Y. p18 Ink4c and Pten Constrain a Positive Regulatory Loop Between Cell Growth and Cell Cycle Control. Molecular and Cellular Biology. 26, 4564-4576:2006. *equal contribution.
13. Pei XH., Bai F., Tsutsui T., Kiyokawa H., Xiong Y. Genetic Evidence for Functional Dependency of p18Ink4c on Cdk4. Molecular and Cellular Biology. 24, 6653-6664: 2004.
用户登录
还没有账号?
立即注册